LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.75 | 84.90 | 37 | 8621 | 0.0043 | -0.1171 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 82.75 | 84.90 | 3980 | 8621 | 0.4616 | 0.7810 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.45 | 84.90 | 120 | 8254 | 0.0145 | 0.0538 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.45 | 84.90 | 3953 | 8254 | 0.4789 | 0.7890 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.45 | 84.90 | 15 | 8254 | 0.0018 | -0.2309 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 84.45 | 84.90 | 3957 | 8254 | 0.4794 | 0.7892 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.16 | 84.90 | 124 | 8141 | 0.0152 | 0.0592 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.16 | 84.90 | 4004 | 8141 | 0.4918 | 0.7956 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.16 | 84.90 | 12 | 8141 | 0.0015 | -0.2571 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 86.16 | 84.90 | 3955 | 8141 | 0.4858 | 0.7923 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.86 | 84.90 | 108 | 7680 | 0.0141 | 0.0377 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.86 | 84.90 | 4105 | 7680 | 0.5345 | 0.8162 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.86 | 84.90 | 3 | 7680 | 0.0004 | -0.4021 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 87.86 | 84.90 | 3851 | 7680 | 0.5014 | 0.7985 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.57 | 84.90 | 87 | 7494 | 0.0116 | 0.0038 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.57 | 84.90 | 4106 | 7494 | 0.5479 | 0.8222 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.57 | 84.90 | 1 | 7494 | 0.0001 | -0.4970 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 89.57 | 84.90 | 3691 | 7494 | 0.4925 | 0.7924 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.27 | 84.90 | 88 | 7420 | 0.0119 | 0.0056 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.27 | 84.90 | 4157 | 7420 | 0.5602 | 0.8282 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 91.27 | 84.90 | 3425 | 7420 | 0.4616 | 0.7741 | MN20160318_Q02 | F04 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.98 | 84.90 | 65 | 7257 | 0.0090 | -0.0408 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.98 | 84.90 | 4155 | 7257 | 0.5725 | 0.8335 | MN20160318_Q02 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.17783 | 92.98 | 84.90 | 1 | 7257 | 0.0001 | -0.4995 | MN20160318_Q02 | F04 |